Position in IBRX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$87,550
+$10,850 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#302
of 401 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Enhancement Group LLC holds $2,033,789 across 3 Biotechnology names. IBRX ranks #3 (4.3% of the industry book) .
All Filings in IBRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,550 | 10,000 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $76,700 | 10,000 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $19,800 | 10,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $24,600 | 10,000 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $26,400 | 10,000 | Shares | Sole | 2025-07-14 | |
| No filing history on record for this holder in this stock. | ||||||